*(as published in the Boston Broadside late 2019 – see data on high level connections to psychiatry and their drugs)

FDA & Mass General Hospital Psychiatry Dept.’s
Hidden Roles Exposed in Antipsychotic Risperdal Drug Settlement

)see data on Deep State Connections to Psychiatric Drugging)

by Kevin Hall
Citizens Commission on Human Rights,
New England Director

Last month, a Philadelphia jury ordered Johnson & Johnson to pay $8 billion to a man who developed lactating breasts (gynecomastia) after taking their antipsychotic drug, Risperdal, starting at age nine. Although the company is also involved in legal settlements for their addictive opiates and other products and plans to appeal to reduce the settlement costs, this is only one of more than 18,000 gynecomastia  lawsuits they face.

$2.2 Billion Later, and More to Come

In 2013, Johnson & Johnson and their subsidiary, Janssen, had to pay the US government $2.2 billion for deceptively marketing Risperdal. Now, in addition to the gynecomastia verdict, J&J is also facing a plethora of lawsuits regarding other side effects of their antipsychotic drug, including but not limited to:  tardive dyskinesia (permanent involuntary muscular movements), extreme weight gain, and diabetes.

Fentanyl, Risperdal …
Fraudulent Marketing and
Complicit Medical Providers

The point of this article isn’t so much the extreme dangers of this powerful tranquilizer, which all antipsychotics are, and this drug company, but how we regularly approve, fraudulently market and keep such drugs on the market despite piles of data showing them to be very dangerous and of very little, if any, help.

Pretty much every major pharmaceutical company has been successfully sued and forced to pay huge False Claims Act settlements to the US government. This Spring, the Boston U.S. Department of Justice criminally prosecuted the top six executives of fentanyl manufacturer Insys. Since pharmaceutical companies are regularly involved in similar fraudulent marketing campaigns with their antipsychotics, ADHD amphetamines and antidepressants that also harm huge portions of the population, shouldn’t their top executives be seeing the inside of a jail cell too?

Influences and Shadow Power Brokeres Behind
the U.S. Medical and Mental Health Systems

The Food and Drug Administration (FDA) is the part of US Health and Human Services (U.S. HHS) that has been entrusted to protect the public safety by such means as their drug approval process and protecting citizens against deceptive marketing and false drug claims. They are also in charge or performing post-market research to ensure the accuracy of the clinical trial data as well as the long-term side effects as clinical trial studies often run for only about six to eight weeks.

Although the FDA is supposed to be on the side of the public, eight of their last nine commissioners joined pharmaceutical companies immediately after stepping down from office. The current U.S. HHS Secretary Alex Azar was general counsel and deputy secretary of U.S. HHS from 2001 to 2007, and then joined Eli Lilly & Co. from 2007 to 2017, wherein he was CEO of ELI Lilly USA, LLC the last half dozen years of that term. Regarding drug safety, not only is that fox guarding the chicken coup, he owns the chicken farm.

Pharmaceutical company leaders are not only in positions of drug approval, but with U.S. HHS/Eli Lilly, they are also approving drug payment rates via Medicaid, Medicare and other insurance which is a major reason why drug costs in the U.S. are far higher than those in any other nation.

For those of you concerned about the Deep State running our government, this and over 600 drug company lobbyists on Capitol Hill alone should give some insight as to how they own our healthcare system via our government. For a little more taste of the connection between power brokers to our government and pharmaceutical/health care leadership, William C. Weldon, CEO of Johnson & Johnson from 2002-2012 was also on the Board of Directors of JP Morgan Chase & Co. from March 2005 – May 2019. Additionally, for those of you who have wondered how Dan Quayle ever qualified to become U.S. Vice-President, possibly is it because President George H. W.  Bush was on Eli Lilly’s Board of Directors just prior to being elected U.S. President and Quayle was a U.S. Senator from Eli Lilly’s home state of Indiana.

On FDA drug approval, the agency also doesn’t test drugs. They simply review the studies paid for by the pharmaceutical companies which have Billion$$ of reasons to conceal the harm caused by their drugs in clinical trials. To make their studies look better to the FDA and general public, they often pay doctors and psychiatrists in prestigious universities and their connected hospitals to do the studies. Some do a good research job while others take the money knowing that positive drug study results are what pharmaceutical companies need for drug approval. They also use these same, sometimes unethical doctors to further market their drugs with misleading information through medical journal articles, public talks, seminars and continuing medical education classes.

MGH: Subcontractor for Marketing Risperdal?

That brings us back to Risperdal. Antipsychotics were always considered too dangerous for children until Massachusetts General Hospital (MGH) psychiatrist Joseph Biederman led the movement to create pediatric bipolar disorder and the eventual American Academy of Child and Adolescent Psychiatry’s 1996 pediatric bipolar guidelines that led to a 40-fold increase in the diagnosis. The new psychiatric standard also told doctors and psychiatrists that not only should they give children antipsychotics for pediatric bipolar, but that the alleged infliction often had underlying disorders with it like ADHD and anxiety that also needed to be drugged which is why we see nearly two million children on these drugs, often as part of even more dangerous psychiatric drug cocktails.

To help push Risperdal as the pediatric bipolar drug of choice, J&J gave Biederman a $280,000 grant and in 2002 spent $700,000 to fund the MGH Johnson & Johnson Center for Pediatric Psychopathology with this psychiatrist as the center’s director.  One of the written objectives of this center was a goal to, “move forward the commercial goals of J&J.” This risks MGH Psychiatry and Biederman as being considered as subcontractors in the marketing of Risperdal, meaning that potentially they could also be part of future lawsuits and criminal actions for damage done by the antipsychotic to children, if civil lawyers and the federal government decide to stop the targeting of children at its roots.

Do yourself a favor by looking at ChildBipolarTimeline.wordpress.com to get all the unscrupulous details behind Biederman’s collusion with J&J that is behind this $8 billion verdict.

Although some good comes out of the FDA, I’m not sure if they may be harming people more than helping when giving their gold seal stamps of approval on drugs, food and medical devices they never directly study and often know are harmful. It’s more like fake science that works as real marketing, as without the FDA, maybe even more of us would look for alternative health first, while others would be more likely to heavily research what we are being prescribed